180 related articles for article (PubMed ID: 36765866)
1. PET/CT with Fibroblast Activation Protein Inhibitors in Breast Cancer: Diagnostic and Theranostic Application-A Literature Review.
Taralli S; Lorusso M; Perrone E; Perotti G; Zagaria L; Calcagni ML
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765866
[TBL] [Abstract][Full Text] [Related]
2. Head-to-Head Comparison of Fibroblast Activation Protein Inhibitors (FAPI) Radiotracers versus [
Treglia G; Muoio B; Roustaei H; Kiamanesh Z; Aryana K; Sadeghi R
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681850
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Diagnostic Efficacy of [
Zhang S; Wang W; Xu T; Ding H; Li Y; Liu H; Huang Y; Liu L; Du T; Zhao Y; Chen Y; Qiu L
Front Oncol; 2022; 12():925100. PubMed ID: 35847877
[TBL] [Abstract][Full Text] [Related]
4. A Systematic Review on the Diagnostic Value of Fibroblast Activation Protein Inhibitor PET/CT in Genitourinary Cancers.
Hagens MJ; van Leeuwen PJ; Wondergem M; Boellaard TN; Sanguedolce F; Oprea-Lager DE; Bex A; Vis AN; van der Poel HG; Mertens LS;
J Nucl Med; 2024 Jun; 65(6):888-896. PubMed ID: 38637140
[TBL] [Abstract][Full Text] [Related]
5. Could Fibroblast Activation Protein (FAP)-Specific Radioligands Be Considered as Pan-Tumor Agents?
Roustaei H; Kiamanesh Z; Askari E; Sadeghi R; Aryana K; Treglia G
Contrast Media Mol Imaging; 2022; 2022():3948873. PubMed ID: 35280710
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of [
Zhao L; Pang Y; Zheng H; Han C; Gu J; Sun L; Wu H; Wu S; Lin Q; Chen H
Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3606-3617. PubMed ID: 33792760
[TBL] [Abstract][Full Text] [Related]
7. Comparison of
Pang Y; Zhao L; Luo Z; Hao B; Wu H; Lin Q; Sun L; Chen H
Radiology; 2021 Feb; 298(2):393-402. PubMed ID: 33258746
[TBL] [Abstract][Full Text] [Related]
8.
Giesel FL; Kratochwil C; Lindner T; Marschalek MM; Loktev A; Lehnert W; Debus J; Jäger D; Flechsig P; Altmann A; Mier W; Haberkorn U
J Nucl Med; 2019 Mar; 60(3):386-392. PubMed ID: 30072500
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography and computed tomography with [
Pang Y; Zhao L; Shang Q; Meng T; Zhao L; Feng L; Wang S; Guo P; Wu X; Lin Q; Wu H; Huang W; Sun L; Chen H
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1322-1337. PubMed ID: 34651226
[TBL] [Abstract][Full Text] [Related]
10. FAPI PET/CT Imaging-An Updated Review.
Chandekar KR; Prashanth A; Vinjamuri S; Kumar R
Diagnostics (Basel); 2023 Jun; 13(12):. PubMed ID: 37370912
[TBL] [Abstract][Full Text] [Related]
11. [
Zheng J; Liu F; Lin K; Zhang L; Huang N; Zheng W; Zhang J; Yao S; Miao W
Mol Imaging Biol; 2022 Dec; 24(6):973-985. PubMed ID: 35945360
[TBL] [Abstract][Full Text] [Related]
12. What radiolabeled FAPI pet can add in breast cancer? A systematic review from literature.
Evangelista L; Filippi L; Schillaci O
Ann Nucl Med; 2023 Aug; 37(8):442-450. PubMed ID: 37341971
[TBL] [Abstract][Full Text] [Related]
13. Accurate preoperative staging with [
Chen S; Chen Z; Zou G; Zheng S; Zheng K; Zhang J; Huang C; Yao S; Miao W
Eur Radiol; 2022 Sep; 32(9):6070-6079. PubMed ID: 35352157
[TBL] [Abstract][Full Text] [Related]
14. Head-to-Head Comparison of [
Wegen S; van Heek L; Linde P; Claus K; Akuamoa-Boateng D; Baues C; Sharma SJ; Schomäcker K; Fischer T; Roth KS; Klußmann JP; Marnitz S; Drzezga A; Kobe C
Mol Imaging Biol; 2022 Dec; 24(6):986-994. PubMed ID: 35771317
[TBL] [Abstract][Full Text] [Related]
15. The Added Value of
Gu B; Xu X; Zhang J; Ou X; Xia Z; Guan Q; Hu S; Yang Z; Song S
J Nucl Med; 2022 Jun; 63(6):875-881. PubMed ID: 34593594
[No Abstract] [Full Text] [Related]
16. Fibroblast Activation Protein Inhibitor PET/CT: A Promising Molecular Imaging Tool.
Sharma P; Singh SS; Gayana S
Clin Nucl Med; 2021 Mar; 46(3):e141-e150. PubMed ID: 33351507
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution, pharmacokinetics, dosimetry of [
Ballal S; Yadav MP; Moon ES; Kramer VS; Roesch F; Kumari S; Tripathi M; ArunRaj ST; Sarswat S; Bal C
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1915-1931. PubMed ID: 33244617
[TBL] [Abstract][Full Text] [Related]
18. Prospective Comparison of
Lan L; Zhang S; Xu T; Liu H; Wang W; Feng Y; Wang L; Chen Y; Qiu L
Radiology; 2022 Sep; 304(3):648-657. PubMed ID: 35579524
[TBL] [Abstract][Full Text] [Related]
19. Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [
Guo W; Pang Y; Yao L; Zhao L; Fan C; Ke J; Guo P; Hao B; Fu H; Xie C; Lin Q; Wu H; Sun L; Chen H
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1604-1617. PubMed ID: 33179149
[TBL] [Abstract][Full Text] [Related]
20. State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis.
Sollini M; Kirienko M; Gelardi F; Fiz F; Gozzi N; Chiti A
Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4396-4414. PubMed ID: 34173007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
